Brief: Reliance Global Group Completes Transformative Investment In Late-Stage Radiopharmaceutical Innovator Innervate Through Ezra’S Biotech Division
May 4 (Reuters) - Reliance Global Group Inc EZRA.O: RELIANCE GLOBAL GROUP COMPLETES TRANSFORMATIVE INVESTMENT IN LATE-STAGE RADIOPHARMACEUTICAL INNOVATOR INNERVATE THROUGH EZRA’S BIOTECH DIVISION Source text: ID:nGNX3H9Qmb Further company coverage: EZRA.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Reliance Global
See all newsBrief: Reliance Global Group Signs LOI To Acquire A GPU Cloud Provider
Subsidiary Sells Employee Benefits Insurance Assets To Altruis Benefit Management
Terminates Loi For Sale Of Altruis Assets On August 14, 2026 - SEC Filing
NASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT REASON NOT AVAILABLE AT 03:58 AM